Valneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine
Oxford Immunotec will perform T cell testing on participants receiving Valneva's vaccine candidate - News - PharmaTimes
Stay updated with breaking news from Peter Wrighton Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oxford Immunotec will perform T cell testing on participants receiving Valneva's vaccine candidate - News - PharmaTimes
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of ... Oxford Immunotec Global PLCJanuary 13, 2021 GMT OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the start of a collaboration with Valneva. The Company will perform T cell testing on participants receiving Valneva’s inactivated whole-virus COVID-19 vaccine ca...
PerkinElmer buying UK diagnostics firm for $591 million By Anissa Gardizy Globe Staff,Updated January 7, 2021, 4:03 p.m. Email to a Friend A PerkinElmer automated workstation, which is used in labs around the world. On Thursday, the company announced it would acquire Oxford Immunotec, which makes tests for diagnosing tuberculosis.- PerkinElmer announced on Thursday it will acquire UK diagnostics company Oxford Immunotec in a deal worth $591 million. The Waltham-based firm makes lab equipment and software for health care companies, drug companies, and food manufacturers, and the move will help...
PerkinElmer, Inc.: PerkinElmer to Acquire Oxford Immunotec Global PLC Transaction expected to be completed in the first half of 2021 PerkinElmer, Inc. (NYSE: PKI) (" Oxford Immunotec" or the " Company") are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec (the " Acquisition"). It is intended that the Acquisition will be implemented by means of a U.K. High Court of Justice-sanctioned scheme of arrangement under Part 26 of the U.K. Companies Act 2006 between Oxford Immunotec and its shareholders (the " Scheme Under the terms of th...
By Andrew Smith Environmental responsibility has now become policy with the vast majority of businesses. But back in 1997, at the time of the groundbreaking Kyoto agreement, it was hardly a consideration. Kyoto tried to commit industrialised nations to cut carbon pollution by 5.2 per cent below 1990 levels. Some have been more successful than others but one way of achieving it was to develop a system of carbon credits which larger businesses paid for. The cash was then used for environmental projects which would hopefully more than...